Your search for smoking cessation returned 291 results

Half of young adult tobacco smokers also have used marijuana in the last 30 days, and co-use occurs on nearly half of the days either substance is used.

Periodontal disease (PD) and atherosclerotic vascular disease (ASVD) share common risk factors, but there is no evidence for a causal relationship between the two, nor evidence that treating PD prevents or alters the outcomes of ASVD.

The introduction of smoke-free legislation in Scotland in 2006 has been associated with a reduction in small for gestational age and preterm delivery.

The addition of nicotine-replacement therapy to behavioral cessation support does not increase the rate of smoking abstinence in pregnant women.

The smoking cessation drug varenicline (VAR) may also reduce alcohol consumption in social drinkers by increasing alcohol’s aversive effects.

For individuals who have quit smoking, use of nicotine replacement therapy (NRT) may not impact relapse rates.

The FDA has notified the public that the smoking cessation aid Chantix (varenicline; Pfizer) may be associated with a small, increased risk of certain cardiovascular events in patients with cardiovascular disease.

Orexigen Therapeutics announced positive results from its Phase 2b trial for Empatic (bupropion SR/zonisamide SR), its investigational combination drug for the treatment of obesity.

The FDA has approved Watson’s over-the-counter nicotine polacrilex gum in coated fruit and cinnamon flavors, the generic equivalent of GlaxoSmithKline Consumer Healthcare’s smoking cessation aid, Nicorette Fruit Chill and Cinnamon Surge Coated gums.

The FDA has notified healthcare professionals and patients that it has required manufacturers of varenicline (Chantix, from Pfizer) and bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL, and Zyban, from GlaxoSmithKline) to add new Boxed Warnings to the product labeling and develop patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms.